Glass House Brands (GLAS) Change in Account Payables (2020 - 2026)

Glass House Brands' (GLAS) quarterly Change in Account Payables came in at $1.9 million in Q1 2026, up 416.01% year-on-year from $359486.6 in Q1 2025, and down 76.57% on a QoQ basis from $7.9 million in Q4 2025.

Glass House Brands (GLAS) Change in Account Payables (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Change in Account Payables data on file, last reported at $1.9 million in Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 416.01% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $8.3 million, a 67.56% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, down 30.86% from the prior year.
  • Change in Account Payables for Q1 2026 stood at $1.9 million, down from $7.9 million in the prior quarter.
  • Over the last five years, Change in Account Payables for GLAS reached as high as $7.9 million in Q4 2025 and fell as low as -$5.8 million in Q3 2025.
  • Historically, Change in Account Payables has averaged $1.7 million across 5 years, with a median of $2.2 million in 2023.
  • On a YoY basis, Change in Account Payables climbed as much as 947.75% in 2025 and fell as far as 533.62% in 2025.
  • Year by year, Change in Account Payables stood at $214000.0 in 2022, then soared by 927.93% to $2.2 million in 2023, then slumped by 142.46% to -$934000.0 in 2024, then jumped by 947.75% to $7.9 million in 2025, then tumbled by 76.57% to $1.9 million in 2026.
  • Per Business Quant data, the three most recent Change in Account Payables figures were $1.9 million in Q1 2026, $7.9 million in Q4 2025, and -$5.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 1.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.86 Mn
Mar 31, 2026 1.86 Mn
Dec 31, 2025 7.92 Mn
Dec 31, 2025 7.92 Mn
Sep 30, 2025 -5.80 Mn
Sep 30, 2025 -5.80 Mn
Jun 30, 2025 4.29 Mn
Jun 30, 2025 4.29 Mn
Mar 31, 2025 -587,000.00
Mar 31, 2025 -587,000.00
Dec 31, 2024 -934,000.00
Dec 31, 2024 -934,000.00
Sep 30, 2024 -916,000.00
Sep 30, 2024 -916,000.00
Jun 30, 2024 7.37 Mn
Jun 30, 2024 7.37 Mn
Mar 31, 2024 2.90 Mn
Mar 31, 2024 2.90 Mn
Dec 31, 2023 2.20 Mn
Dec 31, 2023 2.20 Mn